May 11, 2016 at 7:23 pm
Merus is close to realizing its long awaited Nasdaq IPO worth $65 million. Currently, the cancer specialist has listed Novartis, Pfizer and Johnson and Johnson as companies leading the investments in the firm. The company‚Äôs IPO intends to bank on its current backers. Meanwhile, its current backers...Read More »